D’Ambrosio, Viola
Capolongo, Giovanna
Goldfarb, David
Gambaro, Giovanni
Ferraro, Pietro Manuel http://orcid.org/0000-0002-1379-022X
Article History
Received: 15 May 2021
Revised: 22 September 2021
Accepted: 12 October 2021
First Online: 23 November 2021
Declarations
:
: PMF received consultant fees/grant support from Allena Pharmaceuticals, Alnylam, AstraZeneca, BioHealth Italia, Vifor Fresenius and author royalties from UpToDate. All of the other authors have no potential conflicts of interest to disclose. VDA, GC, and PMF are members of the European Reference Network for Rare Kidney Diseases (ERKNet) – Project ID No 739532.